- Pilot and Feasibility Program The mission of the Pilot and Feasibility (P&F) Program is to foster the development of new investigators and to provide seed support for innovative high-risk diabetes-related research. Dr. Peter Tontonoz assumed the directorship in 2014 and will continue to lead the P&F program in the next cycle. The UCSD/UCLA DRC has an exemplary track record of funding catalytic diabetes research. In the history of our DRC, the P&F Program has funded 82 projects (61 over the last 10 years). Over 90% of these were projects from young investigators looking to establish new independent diabetes research programs. More than 95% of our P&F recipients are still active in diabetes research, providing clear evidence that we are selecting meritorious recipients. Moreover, our P&F-funded investigators have an impressive record of obtaining post-P&F NIH grant support and of publications in high impact journals. Most importantly, many prior UCSD/UCLA DRC P&F awardees are now independent, productive R01-funded faculty members at UCSD/UCLA or at other institutions around the US. Collectively, these achievements underscore the exceptional pipeline of young investigators in our research community and our ability to successfully identify meritorious recipients. Specific Objectives for the P&F Program are to continue to: 1. Promote emerging and innovative diabetes projects and catalyze development of future scientific leaders; 2. Inform and engage diabetes research communities regarding the DRC P&F and its opportunities; 3. Mentor P&F recipients in order to facilitate and accelerate their transition to independent external funding; 4. Leverage institutional investments in the form of matching support, infrastructure outlays, and the development of technologies towards the success of P&F projects; 5. Synergize with other institutional training and research programs; 6. Foster collaborative research among junior and senior scientists, promote leadership skills, and encourage entrepreneurship and the development of intellectual property; 7. Implement oversight and programmatic review of the P&F program and its awardees

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California, San Diego
La Jolla
United States
Zip Code
Seyerle, A A; Sitlani, C M; Noordam, R et al. (2018) Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. Pharmacogenomics J 18:215-226
Gao, Chuan; Tabb, Keri L; Dimitrov, Latchezar M et al. (2018) Exome Sequencing Identifies Genetic Variants Associated with Circulating Lipid Levels in Mexican Americans: The Insulin Resistance Atherosclerosis Family Study (IRASFS). Sci Rep 8:5603
Svensson, Kristoffer; Dent, Jess R; Tahvilian, Shahriar et al. (2018) Defining the contribution of skeletal muscle pyruvate dehydrogenase alpha 1 (Pdha1) to exercise performance and insulin action. Am J Physiol Endocrinol Metab :
Yuan, Xiaomei; Dong, Yi; Tsurushita, Naoya et al. (2018) CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms. JCI Insight 3:
Jo Hodonsky, Chani; Schurmann, Claudia; Schick, Ursula M et al. (2018) Generalization and fine mapping of red blood cell trait genetic associations to multi-ethnic populations: The PAGE Study. Am J Hematol :
Wang, Bo; Rong, Xin; Palladino, Elisa N D et al. (2018) Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis. Cell Stem Cell 22:206-220.e4
Gong, J; Nishimura, K K; Fernandez-Rhodes, L et al. (2018) Trans-ethnic analysis of metabochip data identifies two new loci associated with BMI. Int J Obes (Lond) 42:384-390
Bihlmeyer, Nathan A; Brody, Jennifer A; Smith, Albert Vernon et al. (2018) ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. Circ Genom Precis Med 11:e001758
Hernandez-Carretero, A; Weber, N; La Frano, M R et al. (2018) Obesity-induced changes in lipid mediators persist after weight loss. Int J Obes (Lond) 42:728-736
Prohaska, Thomas A; Que, Xuchu; Diehl, Cody J et al. (2018) Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies. J Immunol 200:1702-1717

Showing the most recent 10 out of 926 publications